Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Juliet Quirk"'
Autor:
Gregor Winkels, Juliet Quirk, Eugene Maraskovsky, Lauren Seddon, Lisa M. Ebert, Jonathan Cebon, Tsin Yee Tai, Leone Morris, Frederick Wittke, Weisan Chen, Ian D. Davis, Judy Browning, Genevieve Whitty, Duncan MacGregor, Lena Miloradovic, Tina Cavicchiolo, Regina Alex, Heather Jackson
Publikováno v:
Immunotherapy. 9(3)
Aim: Pilot clinical trial of NY-ESO-1 (ESO) protein in ISCOMATRIX™ adjuvant pulsed onto peripheral blood dendritic cells (PBDC), to ascertain feasibility, evaluate toxicity and assess induction of ESO-specific immune responses. Patients & methods:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::489033a2253a5eb42179e3980ee0ff1e
https://pubmed.ncbi.nlm.nih.gov/28183192
https://pubmed.ncbi.nlm.nih.gov/28183192
Autor:
Craig Gedye, Judy Browning, Thomas John, Pavel Sluka, Denis Corbeil, Ian D. Davis, Jonathan Cebon, Juliet Quirk, P. Rod Dunbar, Suzanne Svobodova
Publikováno v:
Cancer Immunology, Immunotherapy. 58:1635-1646
"Cancer stem cells" that resist conventional treatments may be a cause of therapeutic failure in melanoma. We report a subpopulation of clonogenic melanoma cells that are characterized by high prominin-1/CD133 expression in melanoma and melanoma cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f91bd68ec92a239acb820d59a761d433
https://doi.org/10.1007/s00262-009-0672-0
https://doi.org/10.1007/s00262-009-0672-0
Autor:
Nektaria Dimopoulos, Lloyd J. Old, Leone Morris, Wendie Hopkins, Juliet Quirk, Jonathan Cebon, Phillip Parente, Weisan Chen, Maureen Stanley, Suzanne Svobodova, Heather Jackson, Maria L Tavarnesi, Duncan MacGregor, Eugene Maraskovsky, Qiyuan Chen, Dania Caron, Tsin Yee Tai, Judy Browning, Tina Cavicchiolo, Ian D. Davis
Publikováno v:
Journal of Immunotherapy. 29:499-511
Flt3 ligand mobilizes dendritic cells (DCs) into blood, allowing generation in vivo of large numbers of DCs for immunotherapy. These immature DCs can be rapidly activated by soluble CD40 ligand (CD40L). We developed a novel overnight method using the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a04bf2ffc60202f8544153420e10687b
https://doi.org/10.1097/01.cji.0000211299.29632.8c
https://doi.org/10.1097/01.cji.0000211299.29632.8c
Publikováno v:
Journal of Urology. 181:310-310
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10227db8422b06ca150ce4f169a56a87
https://doi.org/10.1016/s0022-5347(09)60883-1
https://doi.org/10.1016/s0022-5347(09)60883-1
Autor:
Gedye, Craig, Quirk, Juliet, Browning, Judy, Svobodová, Suzanne, John, Thomas, Sluka, Pavel, Dunbar, P. Rod, Corbeil, Denis, Cebon, Jonathan, Davis, Ian D.
Publikováno v:
Cancer Immunology, Immunotherapy; Oct2009, Vol. 58 Issue 10, p1635-1646, 12p, 1 Color Photograph, 1 Chart, 4 Graphs
Publikováno v:
Asia Pacific Journal of Clinical Oncology. Dec2007 Supplement 2, Vol. 3, pA39-A74. 1p.